Abstract OT-26-01: ABEMACARE: Abemaciclib in combination with endocrine therapy as first line therapy in metastatic breast cancer patients with symptomatic visceral metastases or high tumor burden

Cancer Patients ◽

Metastatic Breast ◽

Tumor Burden ◽

Breast Cancer Patients ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Visceral Metastases

Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial

British Journal of Cancer ◽

10.1038/sj.bjc.6603351 ◽

2006 ◽

Vol 95 (7) ◽

pp. 788-793 ◽

Cited By ~ 43

Author(s):

A Chan ◽

◽

M Martin ◽

M Untch ◽

M G Gil ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Her 2

Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients

European Journal of Cancer ◽

10.1016/j.ejca.2018.03.013 ◽

2018 ◽

Vol 95 ◽

pp. 93-101 ◽

Cited By ~ 14

Author(s):

E. Jacquet ◽

A. Lardy-Cléaud ◽

B. Pistilli ◽

S. Franck ◽

P. Cottu ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Hormone Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

First Line Therapy ◽

Hormone Receptor Positive ◽

Retrospective review of Her2 positive metastatic breast cancer patients who received Pertuzumab and Herceptin as a first line therapy at KFSH&RC (single institute experience) from 2013 to 2016

The Breast ◽

10.1016/s0960-9776(19)30245-0 ◽

2019 ◽

Vol 44 ◽

pp. S64

Author(s):

K. Suleman ◽

A. Mushtaq ◽

E. Haque ◽

A. Badran ◽

D. Ajarim ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Retrospective Review ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Her2 Positive ◽

First Line Therapy ◽

Abstract P1-12-07: A Retrospective Analysis ofnab-Paclitaxel as First-Line Therapy for Metastatic Breast Cancer Patients With Poor Prognostic Factors

10.1158/0008-5472.sabcs12-p1-12-07 ◽

2012 ◽

Cited By ~ 1

Author(s):

J O'Shaughnessy ◽

W Gradishar ◽

P Bhar ◽

J Iglesias

Keyword(s):

Breast Cancer ◽

Prognostic Factors ◽

Retrospective Analysis ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

First Line Therapy ◽

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line therapy.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.1033 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 1033-1033 ◽

Cited By ~ 3

Author(s):

M. Giuliano ◽

A. Giordano ◽

L. Hsu ◽

B. C. Handy ◽

N. T. Ueno ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Prognostic And Predictive Markers

Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients

Expert Review of Anticancer Therapy ◽

10.1586/era.12.107 ◽

2012 ◽

Vol 12 (11) ◽

pp. 1391-1405 ◽

Cited By ~ 15

Author(s):

Lucia Del Mastro ◽

Matteo Lambertini ◽

Claudia Bighin ◽

Alessia Levaggi ◽

Alessia D’Alonzo ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Her2 Positive ◽

First Line Therapy ◽

Docetaxel and pegylated liposomal doxorubicin combination as first-line therapy for metastatic breast cancer patients: results of the phase II GINECO trial CAPYTTOLE

Annals of Oncology ◽

10.1093/annonc/mdp231 ◽

2009 ◽

Vol 20 (12) ◽

pp. 1959-1963 ◽

Cited By ~ 7

Author(s):

C. de la Fouchardière ◽

R. Largillier ◽

Y. Goubely ◽

A.-C. Hardy-Bessard ◽

B. Slama ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Breast Cancer Patients ◽

First Line ◽

First Line Therapy ◽

Long term survival of vinorelbine (N) and trastuzumab (H) as first line therapy for HER2-positive metastatic breast cancer patients (HER2+MBC) (pts)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.587 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 587-587 ◽

Cited By ~ 2

Author(s):

A. Chan ◽

L. Petruzelka ◽

M. Untch ◽

M. Martin ◽

M. Gil Gil ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Her2 Positive ◽

Term Survival ◽

First Line Therapy ◽

Efficacy of First Line Regimens in Metastatic Breast Cancer Patients. Real World Evidence from Instituto Nacional de Cancerologia, Mexico City

The Breast ◽

10.1016/s0960-9776(17)30699-9 ◽

2017 ◽

Vol 36 ◽

pp. S50

Author(s):

Maria Tereza Nieto-Coronel ◽

Claudia Arce Salinas ◽

Ariana Tabares ◽

Jose Luis Aguilar-Ponce

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Mexico City ◽

Real World ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Real World Evidence

375 Effect of adjuvant chemotherapy (ACT) with or without anthracyclines on first line CEF in metastatic breast cancer patients (PTS)

European Journal of Cancer ◽

10.1016/0959-8049(95)95628-j ◽

1995 ◽

Vol 31 ◽

pp. S82

Author(s):

M. Venturini ◽

L. Del Mastro ◽

P. Bruzzi ◽

O. Garrone ◽

M.R. Sertoli ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line